NBSE
NeuBase Therapeutics, Inc. Common Stock
NBSE
NBSE
Delisted
NBSE was delisted on the 10th of May, 2024.
27 hedge funds and large institutions have $1.08M invested in NeuBase Therapeutics, Inc. Common Stock in 2023 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 3 increasing their positions, 10 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
70% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 10
Holders
27
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$311K | |
| 2 | +$13K | |
| 3 | +$7.56K | |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$1K |
| 5 |
JPMorgan Chase & Co
New York
|
+$997 |
Top Sellers
| 1 | -$117K | |
| 2 | -$25K | |
| 3 | -$14.7K | |
| 4 |
State Street
Boston,
Massachusetts
|
-$12.7K |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$10.2K |